rs200283734
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_206965.2(FTCD):c.1358C>T(p.Thr453Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000713 in 1,590,800 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_206965.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTCD | NM_206965.2 | c.1358C>T | p.Thr453Met | missense_variant | Exon 12 of 14 | ENST00000397746.8 | NP_996848.1 | |
FTCD | NM_001320412.2 | c.1358C>T | p.Thr453Met | missense_variant | Exon 12 of 15 | NP_001307341.1 | ||
FTCD | NM_006657.3 | c.1358C>T | p.Thr453Met | missense_variant | Exon 12 of 15 | NP_006648.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000697 AC: 106AN: 152132Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000636 AC: 134AN: 210802Hom.: 0 AF XY: 0.000625 AC XY: 73AN XY: 116848
GnomAD4 exome AF: 0.000715 AC: 1028AN: 1438550Hom.: 2 Cov.: 36 AF XY: 0.000741 AC XY: 530AN XY: 715322
GnomAD4 genome AF: 0.000696 AC: 106AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.000605 AC XY: 45AN XY: 74438
ClinVar
Submissions by phenotype
Glutamate formiminotransferase deficiency Uncertain:2
- -
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 453 of the FTCD protein (p.Thr453Met). This variant is present in population databases (rs200283734, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with FTCD-related conditions. ClinVar contains an entry for this variant (Variation ID: 209155). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FTCD protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.1358C>T (p.T453M) alteration is located in exon 12 (coding exon 12) of the FTCD gene. This alteration results from a C to T substitution at nucleotide position 1358, causing the threonine (T) at amino acid position 453 to be replaced by a methionine (M). The p.T453M alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Intellectual disability Uncertain:1
- -
not provided Benign:1
FTCD: BP4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at